Royal Decree 589/2022 of 19 July, which governs the “transverse training of specialties in health sciences, the procedure and criteria for the proposal of a new title of specialist in health sciences or diplomas of a specific training area, and the review of those”. Established, and established rules applicable to, annual tests of access and training of specific training areas; and access to training places in specialties in health sciences”, already published in BOE. Open the application process for the new specialty “by one or several national scientific societies, legally constituted in relation to the relevant area of expertise in the health sciences, which recognize the representation of at least 70% of professionals in that field or by the National Human Resources Commission on the health system” .
this is The Opportunity That Professionals Dedicated to Clinical Genetics Have Been Waiting For Spain certainly would not remain the only European country without official recognition of this feature, ending decades of demand as it rained in May.
hopefully the process don’t end up in a new disappointment: Royal Decree 639/2014 on Key Subjects, which approved clinical genetics eight years earlier, was annulled by the Supreme Court in 2016 because of a formal flaw. And in 2017 the Interterritorial Council of the National Health System (CISNS) gave the go-ahead to a specialty approved by an independent decree and, since then, nothing.
In May last year, Alexander Raymond, president of the European Society for Human Genetics, sent him Letter to the Minister of Health, Carolina DariusSupporting “the effort of the Spanish clinical genetics community to establish a specialty”. He reminded her that “not only is this characteristic already established in almost all European countries (adopted by 41 states, for example, Portugal, France, Germany, the United Kingdom, the Netherlands, Sweden, Italy and Finland), but , under the Professional Qualification Directive of the European Commission (EC) and under the auspices of the efforts of our society, a pan-European recognition of such experts was established. And he told them that “at a time when genetics is ubiquitous in society and When the era of personalized medicine is emerging, it is important that one of the largest European countries accepts this challenge of modernity.”
It is paradoxical that this feature is not yet recognized in our country. Access to all types of tests, counseling and genetic counseling has been in the SNS service portfolio for years And that the role of genetics is essential to the progress of precision medicine, which is already underway.
The specialty of clinical genetics, though not recognized, exists and is growing and evolving in each hospital as well as each one capable, which has contributed to creating an unacceptable inequality of access to Have given. Service that is required in case of severe oncological, familial and rare pathology,
And we must remember that the government has three programs linked to IMPaCT, Precision Medicine Infrastructure Science and Technology: Predictive Medicine, Data Science and genomic medicine,
When the specialty is approved, it is expected that its National Commission will be created, which will establish the requirements for obtaining the official title, evaluate the needs of specialists and define the accreditation conditions of teaching units. This will begin to order (mainly information) about the technologies being used from the beginning and eliminate the fact that everyone knows about genetics and can be involved and what in this regard. He can do whatever he thinks.
doubts arise What the accreditation process will be for professionals who are already dedicated to clinical genetics,
But step by step: First, legally identify the attribute. and from there, move steadily towards Normalization of quality personalized medicineMore accurate and efficient in diagnosing, treating and monitoring diseases.
